Literature DB >> 21508172

Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting.

Mischa M Jager1, Gezina Weers-Pothoff, Mirjam H A Hermans, Jamie C E Meekelenkamp, Jeroen J A Schellekens, Nicole H M Renders, Alexander C A P Leenders, Peter M Schneeberger, Peter C Wever.   

Abstract

In the peak of the 2009 Q fever outbreak in the Netherlands, we introduced a diagnostic algorithm for acute Q fever with an enzyme-linked immunosorbent assay for immunoglobulin M antibodies to Coxiella burnetii phase II antigens (MII screen) as an initial step. Subsequently, an immunofluorescence assay or PCR was performed depending on the MII screen outcome, date of onset of disease, and inpatient or outpatient setting. The impact of MII screen on the number of immunofluorescence assays performed and the contribution of PCR to diagnosis were retrospectively evaluated in 825 patients referred in a 17-day period. Acute Q fever was diagnosed in 256 patients. The introduction of MII screen reduced the number of immunofluorescence assays performed by more than 80%. In 103 patients, PCR analysis contributed to the diagnosis of acute Q fever. Q fever diagnostics were hampered by the fact that for a high number of patients the date of onset of disease was not provided and the requested follow-up serum samples were not received.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508172      PMCID: PMC3122604          DOI: 10.1128/CVI.00009-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  5 in total

1.  Sustained intensive transmission of Q fever in the south of the Netherlands, 2009.

Authors:  B Schimmer; F Dijkstra; P Vellema; P M Schneeberger; V Hackert; R ter Schegget; C Wijkmans; Y van Duynhoven; W van der Hoek
Journal:  Euro Surveill       Date:  2009-05-14

2.  Q fever. Was Edward Derrick's contribution undervalued?

Authors:  Robin A Cooke
Journal:  Med J Aust       Date:  2008 Dec 1-15       Impact factor: 7.738

3.  Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Authors:  Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

4.  Infectious diseases. Questions abound in Q-fever explosion in the Netherlands.

Authors:  Martin Enserink
Journal:  Science       Date:  2010-01-15       Impact factor: 47.728

Review 5.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

  5 in total
  14 in total

1.  Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera.

Authors:  M C A Wegdam-Blans; C C H Wielders; J Meekelenkamp; J M Korbeeck; T Herremans; H T Tjhie; H A Bijlmer; M P G Koopmans; P M Schneeberger
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

2.  Q Fever endocarditis: does serology predict outcome?

Authors:  Arístides de Alarcón
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic.

Authors:  Cornelia C H Wielders; Joris A F van Loenhout; Gabriëlla Morroy; Ariene Rietveld; Daan W Notermans; Peter C Wever; Nicole H M Renders; Alexander C A P Leenders; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

4.  Comparison of ELISA and indirect immunofluorescent antibody assay detecting Coxiella burnetii IgM phase II for the diagnosis of acute Q fever.

Authors:  J C E Meekelenkamp; P M Schneeberger; P C Wever; A C A P Leenders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

5.  High Coxiella burnetii DNA load in serum during acute Q fever is associated with progression to a serologic profile indicative of chronic Q fever.

Authors:  C C H Wielders; P C A Wijnbergen; N H M Renders; J J A Schellekens; P M Schneeberger; P C Wever; M H A Hermans
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

6.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

7.  Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever.

Authors:  M N T Kremers; R Janssen; C C H Wielders; L M Kampschreur; P M Schneeberger; P M Netten; A de Klerk; H M Hodemaekers; M H A Hermans; D W Notermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

8.  Identification of risk factors for chronic Q fever, the Netherlands.

Authors:  Linda M Kampschreur; Sandra Dekker; Julia C J P Hagenaars; Peter J Lestrade; Nicole H M Renders; Monique G L de Jager-Leclercq; Mirjam H A Hermans; Cornelis A R Groot; Rolf H H Groenwold; Andy I M Hoepelman; Peter C Wever; Jan Jelrik Oosterheert
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

9.  Diagnosis of Acute Q Fever by Detection of Coxiella burnetii DNA using Real-Time PCR, Employing a Commercial Genesig Easy Kit.

Authors:  Jothimani Pradeep; Selvaraj Stephen; Stanley Ambroise; Dhandapany Gunasekaran
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  In vitro and in vivo infectious potential of coxiella burnetii: a study on Belgian livestock isolates.

Authors:  Marcella Mori; Samira Boarbi; Patrick Michel; Raïssa Bakinahe; Katleen Rits; Pierre Wattiau; David Fretin
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.